Last week, CDC didn’t go along with the attempted pediatric vaccine schedule change by tweet. That’s good and important! But it probably only buys us a few more months of (very patchy) access for kids. FDA is the real power broker here. We need pushback on the proposed licensing changes.
Reposted from
Sophia, MPH
This sets up a scenario where average-risk kids are only eligible for last year’s vaccine, but higher-risk kids are recommended to receive the update. Would manufacturers make both versions? There’s little incentive to make more of an outdated vaccine just for a tiny US-only market. 11/
Comments